Glucosamine and Chondroitin Effects
NCT01682694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2014-05-28
Summary
A common starting dose of glucosamine and chondroitin will reduce inflammation as reflected by a reduction in serum C-reactive protein.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Glucosamine and Chondroitin
Glucosamine (1500 mg) and Chondroitin (1200 mg)
- DIETARY_SUPPLEMENT
-
placebo
Sponsors & Collaborators
-
Fred Hutchinson Cancer Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2013-08-31
- Completion
- 2013-08-31
Countries
- United States
Study Locations
More Related Trials
-
Effects of Oral Care With Glutamine on Oral Health, Oral Flora and Incidence of Pneumonia After Neurosurgery With Microbiome Analysis
NCT03867214 ·Status: UNKNOWN ·Phase: PHASE4
-
Glutamate Supplementation in Young Men
NCT03425578 ·Status: COMPLETED ·Phase: NA
-
The Glucosamine-study: The Effect of Glucosamine in Treatment of Chronic Low Back Pain
NCT00404079 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of the Metabolic Effects of Zinc-Amino Acid (ZnAA) Versus Zinc Gluconate
NCT06348056 ·Status: RECRUITING ·Phase: NA
-
Glutathione in Mild Cognitive Impairment
NCT03493178 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Glutathione and Fuel Oxidation in Aging
NCT01870193 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs
NCT02249897 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Oral Glutamine on Mitochondrial Function in CKD
NCT02838979 ·Status: COMPLETED ·Phase: PHASE2
-
Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
NCT04740580 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity
NCT03180775 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy and Safety of an Amino Acid Supplement in Adults
NCT05599282 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Glycoxidative Stress on Human Aging
NCT00579774 ·Status: COMPLETED ·Phase: NA
-
GSH Supplementation on Cold/Flu Symptoms in Older Healthy Adults
NCT02316925 ·Status: WITHDRAWN ·Phase: NA
-
A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder
NCT04886297 ·Status: COMPLETED ·Phase: PHASE3
-
Dietary Effects of Sulfur Amino Acids
NCT00228618 ·Status: COMPLETED
-
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)
NCT02583672 ·Status: COMPLETED ·Phase: PHASE2
-
Sublingual L-GSH Supplementation in Male Subjects With Smoking Habit and/or Hypertension
NCT02125045 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Glutamine on Systemic Inflammation During Human Experimental Endotoxemia
NCT00780520 ·Status: COMPLETED ·Phase: NA
-
Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities
NCT02321579 ·Status: UNKNOWN ·Phase: NA
-
Adenosylmethionine Metabolism in Human Inflammation
NCT02520206 ·Status: UNKNOWN
-
Energetics and Function in Older Humans
NCT02348762 ·Status: COMPLETED ·Phase: PHASE1
-
Role of HIV on Glutathione Synthesis and Oxidative Stress
NCT01355198 ·Status: COMPLETED ·Phase: PHASE1
-
THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME: A RANDOMIZED CLINICAL TRIAL
NCT06004375 ·Status: COMPLETED ·Phase: PHASE3
-
Glutathione and Health With Post-Polio Syndrome
NCT01402570 ·Status: COMPLETED ·Phase: NA
-
The Effects of a Glutathione Precursor (FT061452),on Serum and Intracellular Glutathione Levels
NCT01251315 ·Status: COMPLETED ·Phase: PHASE1